Financial News
All News about Gain Therapeutics Inc
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/14/wall-street-ai9.png?width=1200&height=800&fit=crop)
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
June 14, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Gain Therapeutics: Q4 Earnings Insights
March 26, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/14/movers-image_24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/14/Gold-rally.jpeg?width=1200&height=800&fit=crop)
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2024/02/arm1600-3.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/14/Image33.jpeg?width=1200&height=800&fit=crop)
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
June 14, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/14/movers-image_7.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
Gain Therapeutics Announces Proposed Public Offering
June 13, 2024
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/02/image36.jpeg?width=1200&height=800&fit=crop)
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
April 02, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2024/Parkinsons-disease.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.